Literature DB >> 6194226

Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.

L W Arnold, N J LoCascio, P M Lutz, C A Pennell, D Klapper, G Haughton.   

Abstract

CH12, a murine B cell lymphoma derived in B10 H-2aH-4bp/Wts mice after transfer of SRBC hyperimmunized spleen cells into an adult-thymectomized, sublethally irradiated, syngeneic recipient, is demonstrated to bear surface IgM specific for a determinant found on SRBC and ChRBC. The Ig specificity has been demonstrated by rosetting assays and complement-dependent hemolysis. The removal of CH12 surface IgM by capping with anti-mu or with anti-CH12 idiotype, but not with anti-gamma or with irrelevant anti-idiotype, eliminated the formation of rosettes between CH12 and SRBC or ChRBC. The absorption of CH12 Ig produced in vitro, with either SRBC or ChRBC but not with HRBC, removed all hemolysin activity against SRBC, demonstrating that only one CH12 product was responsible for the reactivity with both SRBC and ChRBC. CH12 has a surface phenotype of a relatively mature B cell expressing surface Ig (IgM-mu,kappa) and la antigens, but lacking Thy-1 or detectable Fc or C3 receptors. CH12 also expresses the antigen Lyt-1. Growth of CH12 in vivo or in vitro results in the generation of up to 3% direct PFC and serum hemolysin, which shows that CH12 is not irretrievably "frozen". The generation of PFC and serum hemolysin is associated with increased population density, and the rate of PFC and serum hemolysin accumulation cannot be explained by simple cell division. A continuously secreting hybridoma derived from CH12 was used to purify the CH12 IgM to facilitate studies of protein sequence and idiotype.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194226

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Tumorigenesis mediated by an antigen receptor.

Authors:  H M Jäck; G Beck-Engeser; G Lee; D Wofsy; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Asbestos activates CH12.LX B-lymphocytes via macrophage signaling.

Authors:  Devon L Rasmussen; Jean C Pfau
Journal:  J Immunotoxicol       Date:  2011-12-01       Impact factor: 3.000

3.  Structure function analysis of the H-2 Abp gene.

Authors:  J A Harton; W Litaker; J A Frelinger; G A Bishop
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Use of the CH lymphomas as models of murine B cell differentiation.

Authors:  G A Bishop; G Haughton
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  The aryl hydrocarbon receptor interacts with ATP5α1, a subunit of the ATP synthase complex, and modulates mitochondrial function.

Authors:  Dorothy M Tappenden; Scott G Lynn; Robert B Crawford; KangAe Lee; Ajith Vengellur; Norbert E Kaminski; Russell S Thomas; John J LaPres
Journal:  Toxicol Appl Pharmacol       Date:  2011-05-12       Impact factor: 4.219

6.  Two separate functions of class II (Ia) molecules: T-cell stimulation and B-cell excitation.

Authors:  R B Corley; N J LoCascio; M Ovnic; G Haughton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Models and mechanisms for signal transduction in B cells.

Authors:  C A Pennell; D W Scott
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

8.  Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen.

Authors:  G A Bishop; G Haughton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

9.  Signaling to a B-cell clone by Ek, but not Ak, does not reflect alteration of Ak genes.

Authors:  G A Bishop; M S McMillan; G Haughton; J A Frelinger
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

10.  Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region.

Authors:  Rebecca A Henseler; Eric J Romer; Courtney E W Sulentic
Journal:  Toxicology       Date:  2009-03-31       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.